Pinsent Masons advises Tan Chong on its tender offer to purchase shares in Zero Co. Ltd

07 Jul 2014 | 10:58 am |

International law firm Pinsent Masons has advised Tan Chong International Limited (“Tan Chong”), a Hong Kong Main Board listed company, on its tender offer to purchase an approximate 28% interest in Zero Co. Ltd (“Zero”), a Tokyo Stock Exchange listed company, for approximately HK$305 million (equivalent to approximately £23 million). Such interests acquired together with interests previously acquired by Tan Chong gives Tan Chong an aggregate current holding of approximately 51% interests in Zero.

The acquisition constituted a Major Transaction for Tan Chong under the Hong Kong Listing Rules. Pinsent Masons advised Tan Chong on the Hong Kong legal and regulatory aspects of the transaction.

Both Tan Chong and Zero are engaged in the automobile-related business. Tan Chong, through the tender offer, is expected to further expand its business in the ASEAN region through the establishment of a closer capital and business alliance with Zero.

The Pinsent Masons Team advising on the deal was led by Corporate Partner Kenneth Chong, assisted by Senior Associate Denise Chan and Trainee Solicitor Kris Cheung in the Hong Kong office.

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

Pinsent Masons advises ALK Capital on its acquisition of Burnley FC

Multinational law firm Pinsent Masons has advised ALK Capital on the acquisition of Burnley Football Club.

Pinsent Masons advises Unbound on financing in fitness start-up VAHA

Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts